

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | COPII vesicle coating (GO:0048208) | 5.15067855 |
| 2 | synaptic vesicle maturation (GO:0016188) | 4.54716986 |
| 3 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.36855821 |
| 4 | synaptic vesicle exocytosis (GO:0016079) | 4.35615152 |
| 5 | glutamate secretion (GO:0014047) | 4.22227599 |
| 6 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.20958123 |
| 7 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.99046712 |
| 8 | regulation of relaxation of muscle (GO:1901077) | 3.89444845 |
| 9 | locomotory exploration behavior (GO:0035641) | 3.89100973 |
| 10 | regulation of synaptic vesicle transport (GO:1902803) | 3.76764744 |
| 11 | neuronal action potential propagation (GO:0019227) | 3.70254590 |
| 12 | negative regulation of thymocyte apoptotic process (GO:0070244) | 3.58581927 |
| 13 | response to pheromone (GO:0019236) | 3.56696828 |
| 14 | protein localization to synapse (GO:0035418) | 3.51648329 |
| 15 | response to hydroperoxide (GO:0033194) | 3.49489057 |
| 16 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.48176612 |
| 17 | neurotransmitter secretion (GO:0007269) | 3.45652155 |
| 18 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.42572001 |
| 19 | cellular potassium ion homeostasis (GO:0030007) | 3.40692258 |
| 20 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.38658945 |
| 21 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.36964635 |
| 22 | activation of protein kinase A activity (GO:0034199) | 3.36854036 |
| 23 | neuron cell-cell adhesion (GO:0007158) | 3.36446467 |
| 24 | vocalization behavior (GO:0071625) | 3.35808595 |
| 25 | exploration behavior (GO:0035640) | 3.28550190 |
| 26 | proline transport (GO:0015824) | 3.28016587 |
| 27 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.27458332 |
| 28 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.24793678 |
| 29 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.23682918 |
| 30 | vesicle transport along microtubule (GO:0047496) | 3.21799653 |
| 31 | vesicle coating (GO:0006901) | 3.16673460 |
| 32 | detection of calcium ion (GO:0005513) | 3.16471163 |
| 33 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.16165376 |
| 34 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.15605485 |
| 35 | nerve growth factor signaling pathway (GO:0038180) | 3.12714397 |
| 36 | cellular response to ethanol (GO:0071361) | 3.07574435 |
| 37 | regulation of synapse structural plasticity (GO:0051823) | 3.06241891 |
| 38 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.03806841 |
| 39 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.01223428 |
| 40 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.01109310 |
| 41 | interkinetic nuclear migration (GO:0022027) | 3.00892845 |
| 42 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.00523234 |
| 43 | beta-amyloid metabolic process (GO:0050435) | 2.99073127 |
| 44 | neuron recognition (GO:0008038) | 2.97826338 |
| 45 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.94811513 |
| 46 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.91735627 |
| 47 | glutamate receptor signaling pathway (GO:0007215) | 2.90844466 |
| 48 | layer formation in cerebral cortex (GO:0021819) | 2.90031345 |
| 49 | negative regulation of neurotransmitter transport (GO:0051589) | 2.89459041 |
| 50 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.88460216 |
| 51 | succinate metabolic process (GO:0006105) | 2.88216316 |
| 52 | carnitine shuttle (GO:0006853) | 2.87776719 |
| 53 | Golgi to endosome transport (GO:0006895) | 2.87688286 |
| 54 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.86884076 |
| 55 | dopamine biosynthetic process (GO:0042416) | 2.86426389 |
| 56 | neurotransmitter transport (GO:0006836) | 2.84863764 |
| 57 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.84153641 |
| 58 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.83913665 |
| 59 | organelle transport along microtubule (GO:0072384) | 2.83910278 |
| 60 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.82948027 |
| 61 | endoplasmic reticulum organization (GO:0007029) | 2.82893302 |
| 62 | membrane budding (GO:0006900) | 2.82612010 |
| 63 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.82206207 |
| 64 | actin-myosin filament sliding (GO:0033275) | 2.81757199 |
| 65 | muscle filament sliding (GO:0030049) | 2.81757199 |
| 66 | regulation of actin filament-based movement (GO:1903115) | 2.81538566 |
| 67 | positive regulation of glycolytic process (GO:0045821) | 2.81297762 |
| 68 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.80635345 |
| 69 | gamma-aminobutyric acid transport (GO:0015812) | 2.79361011 |
| 70 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.78290896 |
| 71 | membrane depolarization during action potential (GO:0086010) | 2.78283771 |
| 72 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.77452494 |
| 73 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.77452494 |
| 74 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.77452494 |
| 75 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.76567103 |
| 76 | Golgi to plasma membrane protein transport (GO:0043001) | 2.76260490 |
| 77 | fatty acid homeostasis (GO:0055089) | 2.76161107 |
| 78 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.75486643 |
| 79 | neuron-neuron synaptic transmission (GO:0007270) | 2.75040808 |
| 80 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.75026264 |
| 81 | regulation of cell communication by electrical coupling (GO:0010649) | 2.74913686 |
| 82 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 2.73185667 |
| 83 | COPI coating of Golgi vesicle (GO:0048205) | 2.71844540 |
| 84 | Golgi transport vesicle coating (GO:0048200) | 2.71844540 |
| 85 | cellular ketone body metabolic process (GO:0046950) | 2.70658912 |
| 86 | tricarboxylic acid cycle (GO:0006099) | 2.70041285 |
| 87 | regulation of neurotransmitter levels (GO:0001505) | 2.68795428 |
| 88 | ether lipid metabolic process (GO:0046485) | 2.67465791 |
| 89 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.67282407 |
| 90 | calcium ion-dependent exocytosis (GO:0017156) | 2.67141499 |
| 91 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.66553821 |
| 92 | actin-mediated cell contraction (GO:0070252) | 2.66540321 |
| 93 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.66377622 |
| 94 | cell communication by electrical coupling (GO:0010644) | 2.66041812 |
| 95 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.65960224 |
| 96 | lipid particle organization (GO:0034389) | 2.65874896 |
| 97 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.64913105 |
| 98 | microtubule nucleation (GO:0007020) | 2.64040593 |
| 99 | righting reflex (GO:0060013) | 2.64022536 |
| 100 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.63795035 |
| 101 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.63257722 |
| 102 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 2.63035505 |
| 103 | long-term synaptic potentiation (GO:0060291) | 2.62799299 |
| 104 | regulation of glucokinase activity (GO:0033131) | 2.62397663 |
| 105 | regulation of hexokinase activity (GO:1903299) | 2.62397663 |
| 106 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.62233514 |
| 107 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.61983231 |
| 108 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.61792554 |
| 109 | positive regulation of muscle hypertrophy (GO:0014742) | 2.61792554 |
| 110 | regulation of neurotransmitter secretion (GO:0046928) | 2.61546952 |
| 111 | vesicle docking (GO:0048278) | 2.61396765 |
| 112 | ketone body metabolic process (GO:1902224) | 2.58336050 |
| 113 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.57804106 |
| 114 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.56764281 |
| 115 | protein targeting to Golgi (GO:0000042) | 2.56718191 |
| 116 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.55628514 |
| 117 | synaptic transmission, glutamatergic (GO:0035249) | 2.55507421 |
| 118 | positive regulation of potassium ion transport (GO:0043268) | 2.55018174 |
| 119 | inositol phosphate catabolic process (GO:0071545) | 2.54739305 |
| 120 | long term synaptic depression (GO:0060292) | 2.54530755 |
| 121 | regulation of vesicle fusion (GO:0031338) | 2.54429756 |
| 122 | signal peptide processing (GO:0006465) | 2.53997529 |
| 123 | positive regulation of dendritic spine development (GO:0060999) | 2.53567306 |
| 124 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.53463774 |
| 125 | regulation of coenzyme metabolic process (GO:0051196) | 2.53038523 |
| 126 | regulation of cofactor metabolic process (GO:0051193) | 2.53038523 |
| 127 | axonal fasciculation (GO:0007413) | 2.52304393 |
| 128 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.52197566 |
| 129 | regulation of synaptic plasticity (GO:0048167) | 2.51640546 |
| 130 | synaptic vesicle endocytosis (GO:0048488) | 2.50171900 |
| 131 | protein targeting to lysosome (GO:0006622) | 2.49914361 |
| 132 | establishment of protein localization to vacuole (GO:0072666) | 2.49914361 |
| 133 | protein targeting to vacuole (GO:0006623) | 2.49914361 |
| 134 | positive regulation of protein autophosphorylation (GO:0031954) | 2.49449216 |
| 135 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.48775137 |
| 136 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.48680441 |
| 137 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.48680441 |
| 138 | negative regulation of dendrite development (GO:2000171) | 2.48645234 |
| 139 | alanine transport (GO:0032328) | 2.48494983 |
| 140 | short-chain fatty acid metabolic process (GO:0046459) | 2.48029732 |
| 141 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.47980131 |
| 142 | labyrinthine layer development (GO:0060711) | 2.47186332 |
| 143 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.47037310 |
| 144 | mRNA modification (GO:0016556) | 2.46175113 |
| 145 | regulation of postsynaptic membrane potential (GO:0060078) | 2.45709982 |
| 146 | synaptic vesicle transport (GO:0048489) | 2.45593151 |
| 147 | establishment of synaptic vesicle localization (GO:0097480) | 2.45593151 |
| 148 | establishment of vesicle localization (GO:0051650) | 2.45574708 |
| 149 | sodium ion export (GO:0071436) | 2.45558128 |
| 150 | glycogen catabolic process (GO:0005980) | 2.45126010 |
| 151 | transmission of nerve impulse (GO:0019226) | 2.45018375 |
| 152 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.44558388 |
| 153 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.44405686 |
| 154 | presynaptic membrane assembly (GO:0097105) | 2.43745410 |
| 155 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.42412907 |
| 156 | carnitine transport (GO:0015879) | 2.42403200 |
| 157 | amino-acid betaine transport (GO:0015838) | 2.42403200 |
| 158 | relaxation of cardiac muscle (GO:0055119) | 2.42164796 |
| 159 | urinary tract smooth muscle contraction (GO:0014848) | 2.42011672 |
| 160 | establishment of protein localization to Golgi (GO:0072600) | 2.41866598 |
| 161 | regulation of Rac protein signal transduction (GO:0035020) | 2.41477020 |
| 162 | regulation of dendritic spine development (GO:0060998) | 2.39864097 |
| 163 | axon cargo transport (GO:0008088) | 2.39507241 |
| 164 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.39463970 |
| 165 | inositol phosphate dephosphorylation (GO:0046855) | 2.39175677 |
| 166 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.39175677 |
| 167 | fatty acid transmembrane transport (GO:1902001) | 2.38461607 |
| 168 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.38061228 |
| 169 | innervation (GO:0060384) | 2.37963615 |
| 170 | potassium ion import (GO:0010107) | 2.37425389 |
| 171 | nucleus localization (GO:0051647) | 2.36430459 |
| 172 | cardiac muscle hypertrophy (GO:0003300) | 2.35743992 |
| 173 | membrane depolarization (GO:0051899) | 2.35438647 |
| 174 | poly(A)+ mRNA export from nucleus (GO:0016973) | 2.31440237 |
| 175 | prepulse inhibition (GO:0060134) | 2.30915331 |
| 176 | glucan catabolic process (GO:0009251) | 2.30657840 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.56978719 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.67084421 |
| 3 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.68990220 |
| 4 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.66668917 |
| 5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.59181811 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.51933769 |
| 7 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.37581098 |
| 8 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.30447928 |
| 9 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.26041149 |
| 10 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.21680473 |
| 11 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.11724152 |
| 12 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.09313310 |
| 13 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.08577286 |
| 14 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.06884424 |
| 15 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.05205912 |
| 16 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.04073543 |
| 17 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.01943073 |
| 18 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.01943073 |
| 19 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.97548690 |
| 20 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.95916636 |
| 21 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.94635302 |
| 22 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.93869473 |
| 23 | P300_19829295_ChIP-Seq_ESCs_Human | 1.92765714 |
| 24 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.90500944 |
| 25 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.88419869 |
| 26 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.87371111 |
| 27 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.83161035 |
| 28 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.82035158 |
| 29 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.80530169 |
| 30 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.77612100 |
| 31 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.76480181 |
| 32 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.74512493 |
| 33 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.74327674 |
| 34 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.74090583 |
| 35 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.73939200 |
| 36 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.71580987 |
| 37 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.71058941 |
| 38 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.70588699 |
| 39 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.70383680 |
| 40 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.69994736 |
| 41 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.69861258 |
| 42 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.69555436 |
| 43 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.68308146 |
| 44 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.67924985 |
| 45 | GATA1_22025678_ChIP-Seq_K562_Human | 1.67226494 |
| 46 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.66331239 |
| 47 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.65345827 |
| 48 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.64963749 |
| 49 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.62472540 |
| 50 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.62239326 |
| 51 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.62190646 |
| 52 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.59432278 |
| 53 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.56712478 |
| 54 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.56090756 |
| 55 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.55437862 |
| 56 | EWS_26573619_Chip-Seq_HEK293_Human | 1.54243005 |
| 57 | AR_25329375_ChIP-Seq_VCAP_Human | 1.52672507 |
| 58 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.52130653 |
| 59 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.51910599 |
| 60 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.51529067 |
| 61 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.49220105 |
| 62 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.48548939 |
| 63 | TP53_16413492_ChIP-PET_HCT116_Human | 1.47298930 |
| 64 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.47079989 |
| 65 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.45408991 |
| 66 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.45159349 |
| 67 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.45123801 |
| 68 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.42572942 |
| 69 | FUS_26573619_Chip-Seq_HEK293_Human | 1.42243368 |
| 70 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.41120063 |
| 71 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.39131452 |
| 72 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.38134321 |
| 73 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.38078098 |
| 74 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.37866598 |
| 75 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.37821042 |
| 76 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.37104404 |
| 77 | STAT3_23295773_ChIP-Seq_U87_Human | 1.35822596 |
| 78 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.35244799 |
| 79 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.34954399 |
| 80 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.34233999 |
| 81 | VDR_22108803_ChIP-Seq_LS180_Human | 1.33150623 |
| 82 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.30801125 |
| 83 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.30060245 |
| 84 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.29265084 |
| 85 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.28102899 |
| 86 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.27518230 |
| 87 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.25617136 |
| 88 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.25407247 |
| 89 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.24210758 |
| 90 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.24210758 |
| 91 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.24175763 |
| 92 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.23631428 |
| 93 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.22925868 |
| 94 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.22540362 |
| 95 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.21896237 |
| 96 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.21413474 |
| 97 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.20367106 |
| 98 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.20328748 |
| 99 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.20098691 |
| 100 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.18882006 |
| 101 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.18287613 |
| 102 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.18051300 |
| 103 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.18051300 |
| 104 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.16544389 |
| 105 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.15037397 |
| 106 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.14903980 |
| 107 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.14126763 |
| 108 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.13858287 |
| 109 | JUN_21703547_ChIP-Seq_K562_Human | 1.13332098 |
| 110 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.12806196 |
| 111 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.12682319 |
| 112 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.11007483 |
| 113 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.09131099 |
| 114 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.09062988 |
| 115 | KDM2B_26808549_Chip-Seq_REH_Human | 1.08837512 |
| 116 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.08681358 |
| 117 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.08384646 |
| 118 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.08338443 |
| 119 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.08130219 |
| 120 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.08026207 |
| 121 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.07348898 |
| 122 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.07099614 |
| 123 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.07062384 |
| 124 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.05508588 |
| 125 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.04269108 |
| 126 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.03963281 |
| 127 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.03653158 |
| 128 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.03567657 |
| 129 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.02878014 |
| 130 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.02571080 |
| 131 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.00847140 |
| 132 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.99495193 |
| 133 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.99382938 |
| 134 | * AR_19668381_ChIP-Seq_PC3_Human | 0.98836997 |
| 135 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.97801838 |
| 136 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.97345148 |
| 137 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.97218491 |
| 138 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.96983178 |
| 139 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.96792079 |
| 140 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.96631215 |
| 141 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.95527292 |
| 142 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.93312873 |
| 143 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.93061358 |
| 144 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91872248 |
| 145 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.91787407 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.45145939 |
| 2 | MP0003880_abnormal_central_pattern | 4.30658900 |
| 3 | MP0010234_abnormal_vibrissa_follicle | 4.00686266 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.13924383 |
| 5 | MP0005187_abnormal_penis_morphology | 3.10287434 |
| 6 | MP0004270_analgesia | 3.06792703 |
| 7 | MP0002009_preneoplasia | 2.94045434 |
| 8 | MP0001968_abnormal_touch/_nociception | 2.86997641 |
| 9 | MP0009745_abnormal_behavioral_response | 2.62588863 |
| 10 | MP0006276_abnormal_autonomic_nervous | 2.57143295 |
| 11 | MP0009046_muscle_twitch | 2.56466673 |
| 12 | MP0008057_abnormal_DNA_replication | 2.55300956 |
| 13 | MP0002735_abnormal_chemical_nociception | 2.54696200 |
| 14 | MP0005451_abnormal_body_composition | 2.47680466 |
| 15 | MP0000569_abnormal_digit_pigmentation | 2.47624712 |
| 16 | MP0002064_seizures | 2.47521396 |
| 17 | MP0010352_gastrointestinal_tract_polyps | 2.46394985 |
| 18 | MP0002063_abnormal_learning/memory/cond | 2.44013098 |
| 19 | MP0002877_abnormal_melanocyte_morpholog | 2.41899209 |
| 20 | MP0002909_abnormal_adrenal_gland | 2.32495473 |
| 21 | MP0002736_abnormal_nociception_after | 2.27064374 |
| 22 | MP0002837_dystrophic_cardiac_calcinosis | 2.27057662 |
| 23 | MP0002734_abnormal_mechanical_nocicepti | 2.22306172 |
| 24 | MP0002272_abnormal_nervous_system | 2.17903067 |
| 25 | MP0003329_amyloid_beta_deposits | 2.10012308 |
| 26 | MP0002572_abnormal_emotion/affect_behav | 2.08054637 |
| 27 | MP0009780_abnormal_chondrocyte_physiolo | 2.02876702 |
| 28 | MP0005423_abnormal_somatic_nervous | 1.99487188 |
| 29 | MP0000372_irregular_coat_pigmentation | 1.97733225 |
| 30 | MP0005646_abnormal_pituitary_gland | 1.91890494 |
| 31 | MP0002733_abnormal_thermal_nociception | 1.91550876 |
| 32 | MP0001486_abnormal_startle_reflex | 1.87536997 |
| 33 | MP0000013_abnormal_adipose_tissue | 1.80278810 |
| 34 | MP0002139_abnormal_hepatobiliary_system | 1.78731032 |
| 35 | MP0008438_abnormal_cutaneous_collagen | 1.77571844 |
| 36 | MP0001984_abnormal_olfaction | 1.77085138 |
| 37 | MP0001501_abnormal_sleep_pattern | 1.75190759 |
| 38 | MP0002067_abnormal_sensory_capabilities | 1.73496748 |
| 39 | MP0002269_muscular_atrophy | 1.73019572 |
| 40 | MP0002166_altered_tumor_susceptibility | 1.72119662 |
| 41 | MP0004145_abnormal_muscle_electrophysio | 1.69138510 |
| 42 | MP0005386_behavior/neurological_phenoty | 1.68076547 |
| 43 | MP0004924_abnormal_behavior | 1.68076547 |
| 44 | MP0001440_abnormal_grooming_behavior | 1.66773646 |
| 45 | MP0001970_abnormal_pain_threshold | 1.65366555 |
| 46 | MP0003633_abnormal_nervous_system | 1.61947312 |
| 47 | MP0002095_abnormal_skin_pigmentation | 1.61234485 |
| 48 | MP0005645_abnormal_hypothalamus_physiol | 1.59885732 |
| 49 | MP0002822_catalepsy | 1.58138424 |
| 50 | MP0005535_abnormal_body_temperature | 1.55785502 |
| 51 | MP0004215_abnormal_myocardial_fiber | 1.54952678 |
| 52 | MP0008569_lethality_at_weaning | 1.52167985 |
| 53 | MP0001879_abnormal_lymphatic_vessel | 1.47382993 |
| 54 | MP0003122_maternal_imprinting | 1.45116487 |
| 55 | MP0004130_abnormal_muscle_cell | 1.44418437 |
| 56 | MP0000751_myopathy | 1.42077830 |
| 57 | MP0002184_abnormal_innervation | 1.41476694 |
| 58 | MP0000759_abnormal_skeletal_muscle | 1.40879902 |
| 59 | MP0004043_abnormal_pH_regulation | 1.40595511 |
| 60 | MP0005365_abnormal_bile_salt | 1.39782504 |
| 61 | MP0002557_abnormal_social/conspecific_i | 1.38714069 |
| 62 | MP0004134_abnormal_chest_morphology | 1.36601718 |
| 63 | MP0004811_abnormal_neuron_physiology | 1.35356271 |
| 64 | MP0003787_abnormal_imprinting | 1.34524131 |
| 65 | MP0000604_amyloidosis | 1.31842574 |
| 66 | MP0001502_abnormal_circadian_rhythm | 1.29992003 |
| 67 | MP0003195_calcinosis | 1.29760779 |
| 68 | MP0005085_abnormal_gallbladder_physiolo | 1.27740659 |
| 69 | MP0002971_abnormal_brown_adipose | 1.26934031 |
| 70 | MP0000015_abnormal_ear_pigmentation | 1.26258542 |
| 71 | MP0004858_abnormal_nervous_system | 1.25116903 |
| 72 | MP0000003_abnormal_adipose_tissue | 1.22868595 |
| 73 | MP0000462_abnormal_digestive_system | 1.22736091 |
| 74 | MP0001661_extended_life_span | 1.22645629 |
| 75 | MP0000955_abnormal_spinal_cord | 1.22227741 |
| 76 | MP0004142_abnormal_muscle_tone | 1.21833631 |
| 77 | MP0002876_abnormal_thyroid_physiology | 1.21683055 |
| 78 | MP0000427_abnormal_hair_cycle | 1.21360124 |
| 79 | MP0003631_nervous_system_phenotype | 1.21061722 |
| 80 | MP0000778_abnormal_nervous_system | 1.20931978 |
| 81 | MP0006054_spinal_hemorrhage | 1.20390965 |
| 82 | MP0002106_abnormal_muscle_physiology | 1.19724001 |
| 83 | MP0003252_abnormal_bile_duct | 1.18887888 |
| 84 | MP0002332_abnormal_exercise_endurance | 1.18858407 |
| 85 | MP0010386_abnormal_urinary_bladder | 1.17532487 |
| 86 | MP0009697_abnormal_copulation | 1.17472313 |
| 87 | MP0004036_abnormal_muscle_relaxation | 1.16138606 |
| 88 | MP0003690_abnormal_glial_cell | 1.14329257 |
| 89 | MP0002066_abnormal_motor_capabilities/c | 1.13979134 |
| 90 | MP0003091_abnormal_cell_migration | 1.12555016 |
| 91 | MP0006138_congestive_heart_failure | 1.09574999 |
| 92 | MP0006036_abnormal_mitochondrial_physio | 1.08597292 |
| 93 | MP0004484_altered_response_of | 1.07856676 |
| 94 | MP0004087_abnormal_muscle_fiber | 1.07724137 |
| 95 | MP0001529_abnormal_vocalization | 1.07029618 |
| 96 | MP0003183_abnormal_peptide_metabolism | 1.06744617 |
| 97 | MP0002229_neurodegeneration | 1.05381099 |
| 98 | MP0008875_abnormal_xenobiotic_pharmacok | 1.04436958 |
| 99 | MP0002006_tumorigenesis | 1.03959962 |
| 100 | MP0003868_abnormal_feces_composition | 1.03341482 |
| 101 | MP0005379_endocrine/exocrine_gland_phen | 1.02284962 |
| 102 | MP0001905_abnormal_dopamine_level | 1.01514577 |
| 103 | MP0002882_abnormal_neuron_morphology | 1.01179684 |
| 104 | MP0000747_muscle_weakness | 1.00232907 |
| 105 | MP0004085_abnormal_heartbeat | 0.98716106 |
| 106 | MP0005253_abnormal_eye_physiology | 0.98363404 |
| 107 | MP0003632_abnormal_nervous_system | 0.97907037 |
| 108 | MP0003221_abnormal_cardiomyocyte_apopto | 0.95504836 |
| 109 | MP0000733_abnormal_muscle_development | 0.95424898 |
| 110 | MP0002090_abnormal_vision | 0.94658525 |
| 111 | MP0006035_abnormal_mitochondrial_morpho | 0.94363871 |
| 112 | MP0005551_abnormal_eye_electrophysiolog | 0.93104975 |
| 113 | MP0000647_abnormal_sebaceous_gland | 0.93017135 |
| 114 | MP0003879_abnormal_hair_cell | 0.91823096 |
| 115 | MP0002078_abnormal_glucose_homeostasis | 0.91513951 |
| 116 | MP0005369_muscle_phenotype | 0.91222722 |
| 117 | MP0002396_abnormal_hematopoietic_system | 0.91091631 |
| 118 | MP0010368_abnormal_lymphatic_system | 0.90278839 |
| 119 | MP0002638_abnormal_pupillary_reflex | 0.89993968 |
| 120 | MP0005332_abnormal_amino_acid | 0.89933392 |
| 121 | MP0010678_abnormal_skin_adnexa | 0.89734883 |
| 122 | MP0008874_decreased_physiological_sensi | 0.89185561 |
| 123 | MP0010094_abnormal_chromosome_stability | 0.89175181 |
| 124 | MP0005330_cardiomyopathy | 0.89131647 |
| 125 | MP0001177_atelectasis | 0.87813332 |
| 126 | MP0003172_abnormal_lysosome_physiology | 0.87646164 |
| 127 | MP0000920_abnormal_myelination | 0.87532285 |
| 128 | MP0005275_abnormal_skin_tensile | 0.87251547 |
| 129 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.86793304 |
| 130 | MP0005171_absent_coat_pigmentation | 0.85059068 |
| 131 | MP0000749_muscle_degeneration | 0.83798876 |
| 132 | MP0005266_abnormal_metabolism | 0.82376785 |
| 133 | MP0005620_abnormal_muscle_contractility | 0.81646838 |
| 134 | MP0001243_abnormal_dermal_layer | 0.81242240 |
| 135 | MP0002896_abnormal_bone_mineralization | 0.80591711 |
| 136 | MP0002069_abnormal_eating/drinking_beha | 0.79964723 |
| 137 | MP0000230_abnormal_systemic_arterial | 0.78934250 |
| 138 | MP0003283_abnormal_digestive_organ | 0.78298455 |
| 139 | MP0005360_urolithiasis | 0.78094124 |
| 140 | MP0004147_increased_porphyrin_level | 0.77878977 |
| 141 | MP0003137_abnormal_impulse_conducting | 0.77380969 |
| 142 | MP0010329_abnormal_lipoprotein_level | 0.77217251 |
| 143 | MP0003646_muscle_fatigue | 0.75877867 |
| 144 | MP0002972_abnormal_cardiac_muscle | 0.75855267 |
| 145 | MP0002118_abnormal_lipid_homeostasis | 0.74689382 |
| 146 | MP0005623_abnormal_meninges_morphology | 0.74633675 |
| 147 | MP0003656_abnormal_erythrocyte_physiolo | 0.74405263 |
| 148 | MP0001664_abnormal_digestion | 0.73751569 |
| 149 | MP0008872_abnormal_physiological_respon | 0.73378745 |
| 150 | MP0005248_abnormal_Harderian_gland | 0.72871036 |
| 151 | MP0003045_fibrosis | 0.71786924 |
| 152 | MP0004084_abnormal_cardiac_muscle | 0.71570454 |
| 153 | MP0005220_abnormal_exocrine_pancreas | 0.70305681 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 4.55523916 |
| 2 | Pheochromocytoma (HP:0002666) | 4.23030752 |
| 3 | Hypoplasia of the thymus (HP:0000778) | 4.17039098 |
| 4 | Muscle fiber inclusion bodies (HP:0100299) | 4.03332660 |
| 5 | B lymphocytopenia (HP:0010976) | 4.00549897 |
| 6 | Thyroiditis (HP:0100646) | 3.97609336 |
| 7 | Nemaline bodies (HP:0003798) | 3.92996494 |
| 8 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.86939293 |
| 9 | Neuroendocrine neoplasm (HP:0100634) | 3.81068908 |
| 10 | Visual hallucinations (HP:0002367) | 3.79164341 |
| 11 | Exercise-induced muscle cramps (HP:0003710) | 3.60991411 |
| 12 | Atonic seizures (HP:0010819) | 3.54828986 |
| 13 | Epileptic encephalopathy (HP:0200134) | 3.50864022 |
| 14 | Focal seizures (HP:0007359) | 3.45940241 |
| 15 | Myokymia (HP:0002411) | 3.44209215 |
| 16 | Absence seizures (HP:0002121) | 3.35545718 |
| 17 | Hyperventilation (HP:0002883) | 3.33809134 |
| 18 | Agitation (HP:0000713) | 3.31282113 |
| 19 | Severe combined immunodeficiency (HP:0004430) | 3.30506221 |
| 20 | Papillary thyroid carcinoma (HP:0002895) | 3.28818895 |
| 21 | Abnormality of B cell number (HP:0010975) | 3.28059036 |
| 22 | Type 1 muscle fiber predominance (HP:0003803) | 3.26970966 |
| 23 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.17913861 |
| 24 | Subaortic stenosis (HP:0001682) | 3.17913861 |
| 25 | Truncal ataxia (HP:0002078) | 3.17141257 |
| 26 | Febrile seizures (HP:0002373) | 3.07727239 |
| 27 | Ketoacidosis (HP:0001993) | 3.07619172 |
| 28 | Papilledema (HP:0001085) | 3.06668728 |
| 29 | Bundle branch block (HP:0011710) | 3.03074240 |
| 30 | Long clavicles (HP:0000890) | 3.02237249 |
| 31 | Progressive cerebellar ataxia (HP:0002073) | 3.02189234 |
| 32 | Generalized tonic-clonic seizures (HP:0002069) | 2.99967654 |
| 33 | Calf muscle hypertrophy (HP:0008981) | 2.93416050 |
| 34 | Dialeptic seizures (HP:0011146) | 2.91792409 |
| 35 | Poor eye contact (HP:0000817) | 2.91116806 |
| 36 | Anxiety (HP:0000739) | 2.86880812 |
| 37 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.85436821 |
| 38 | Action tremor (HP:0002345) | 2.82330257 |
| 39 | Distal arthrogryposis (HP:0005684) | 2.81571803 |
| 40 | Hypoglycemic coma (HP:0001325) | 2.79195504 |
| 41 | Frequent falls (HP:0002359) | 2.76103122 |
| 42 | Hypoproteinemia (HP:0003075) | 2.75705053 |
| 43 | Rhabdomyolysis (HP:0003201) | 2.69898455 |
| 44 | Combined immunodeficiency (HP:0005387) | 2.67161069 |
| 45 | Abnormal social behavior (HP:0012433) | 2.62281569 |
| 46 | Impaired social interactions (HP:0000735) | 2.62281569 |
| 47 | Panhypogammaglobulinemia (HP:0003139) | 2.61113116 |
| 48 | Scanning speech (HP:0002168) | 2.60064607 |
| 49 | Depression (HP:0000716) | 2.57063685 |
| 50 | Thyroid carcinoma (HP:0002890) | 2.54593946 |
| 51 | Supranuclear gaze palsy (HP:0000605) | 2.51990391 |
| 52 | T lymphocytopenia (HP:0005403) | 2.51392923 |
| 53 | Ketosis (HP:0001946) | 2.50224900 |
| 54 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.49318904 |
| 55 | Abnormality of alanine metabolism (HP:0010916) | 2.49318904 |
| 56 | Hyperalaninemia (HP:0003348) | 2.49318904 |
| 57 | Abnormality of the calf musculature (HP:0001430) | 2.48998712 |
| 58 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.47805667 |
| 59 | Hypoglycemic seizures (HP:0002173) | 2.46398462 |
| 60 | Progressive inability to walk (HP:0002505) | 2.44328464 |
| 61 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.42845961 |
| 62 | Hyporeflexia of lower limbs (HP:0002600) | 2.42157140 |
| 63 | EMG: myopathic abnormalities (HP:0003458) | 2.40767795 |
| 64 | Termporal pattern (HP:0011008) | 2.40305213 |
| 65 | Insidious onset (HP:0003587) | 2.40305213 |
| 66 | Broad-based gait (HP:0002136) | 2.38702827 |
| 67 | Drooling (HP:0002307) | 2.35630685 |
| 68 | Excessive salivation (HP:0003781) | 2.35630685 |
| 69 | Amyotrophic lateral sclerosis (HP:0007354) | 2.34600753 |
| 70 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.31842751 |
| 71 | Gaze-evoked nystagmus (HP:0000640) | 2.31320055 |
| 72 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.31069878 |
| 73 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.30179772 |
| 74 | Exercise-induced myalgia (HP:0003738) | 2.29530875 |
| 75 | Limb dystonia (HP:0002451) | 2.26220509 |
| 76 | Type II lissencephaly (HP:0007260) | 2.25620231 |
| 77 | Neurofibrillary tangles (HP:0002185) | 2.24656748 |
| 78 | Dysdiadochokinesis (HP:0002075) | 2.24422903 |
| 79 | Retinal dysplasia (HP:0007973) | 2.24052387 |
| 80 | Difficulty running (HP:0009046) | 2.21397756 |
| 81 | Rimmed vacuoles (HP:0003805) | 2.20056599 |
| 82 | Ankle clonus (HP:0011448) | 2.17407601 |
| 83 | Status epilepticus (HP:0002133) | 2.17350865 |
| 84 | Symptomatic seizures (HP:0011145) | 2.16218008 |
| 85 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.14982085 |
| 86 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.14982085 |
| 87 | Epileptiform EEG discharges (HP:0011182) | 2.14907088 |
| 88 | Postural instability (HP:0002172) | 2.14658288 |
| 89 | Cerebral inclusion bodies (HP:0100314) | 2.14566511 |
| 90 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.14196238 |
| 91 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.13879002 |
| 92 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.13263362 |
| 93 | Fetal akinesia sequence (HP:0001989) | 2.10097488 |
| 94 | EEG with generalized epileptiform discharges (HP:0011198) | 2.09283693 |
| 95 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.09271865 |
| 96 | Inability to walk (HP:0002540) | 2.08057745 |
| 97 | Acute necrotizing encephalopathy (HP:0006965) | 2.05221432 |
| 98 | Hyperglycemia (HP:0003074) | 2.04990741 |
| 99 | Abnormal eating behavior (HP:0100738) | 2.04662734 |
| 100 | Hypokinesia (HP:0002375) | 2.03487240 |
| 101 | Bradykinesia (HP:0002067) | 2.03257128 |
| 102 | Impaired smooth pursuit (HP:0007772) | 2.02716812 |
| 103 | Blue irides (HP:0000635) | 2.02569005 |
| 104 | Conjunctival telangiectasia (HP:0000524) | 2.02411658 |
| 105 | Progressive macrocephaly (HP:0004481) | 2.01925928 |
| 106 | Dysmetria (HP:0001310) | 2.01077041 |
| 107 | Myoglobinuria (HP:0002913) | 2.00918038 |
| 108 | Abnormality of T cell number (HP:0011839) | 2.00785414 |
| 109 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.00344492 |
| 110 | Urinary urgency (HP:0000012) | 2.00122851 |
| 111 | Cerebral hemorrhage (HP:0001342) | 1.98634592 |
| 112 | Acute encephalopathy (HP:0006846) | 1.98585654 |
| 113 | Athetosis (HP:0002305) | 1.98380519 |
| 114 | Sensorimotor neuropathy (HP:0007141) | 1.98174163 |
| 115 | Asymmetric septal hypertrophy (HP:0001670) | 1.97154720 |
| 116 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.96531190 |
| 117 | Amblyopia (HP:0000646) | 1.94587989 |
| 118 | Sudden death (HP:0001699) | 1.91812207 |
| 119 | Poor speech (HP:0002465) | 1.91512782 |
| 120 | Hypsarrhythmia (HP:0002521) | 1.91307594 |
| 121 | Failure to thrive in infancy (HP:0001531) | 1.91099336 |
| 122 | Cutaneous melanoma (HP:0012056) | 1.91046660 |
| 123 | Fair hair (HP:0002286) | 1.89952731 |
| 124 | Hepatic necrosis (HP:0002605) | 1.88069309 |
| 125 | Fatigue (HP:0012378) | 1.87850951 |
| 126 | Gait imbalance (HP:0002141) | 1.87401028 |
| 127 | Oligomenorrhea (HP:0000876) | 1.86881057 |
| 128 | Lower limb muscle weakness (HP:0007340) | 1.85654852 |
| 129 | Psychosis (HP:0000709) | 1.84031890 |
| 130 | Tetraparesis (HP:0002273) | 1.83726372 |
| 131 | Gait ataxia (HP:0002066) | 1.83563327 |
| 132 | Central scotoma (HP:0000603) | 1.82826223 |
| 133 | Absent speech (HP:0001344) | 1.82684380 |
| 134 | Delayed gross motor development (HP:0002194) | 1.81866628 |
| 135 | Lower limb hyperreflexia (HP:0002395) | 1.80921830 |
| 136 | Generalized hypopigmentation of hair (HP:0011358) | 1.80132648 |
| 137 | Diminished movement (HP:0002374) | 1.79297696 |
| 138 | Polyphagia (HP:0002591) | 1.78969859 |
| 139 | Abnormal EKG (HP:0003115) | 1.78678427 |
| 140 | Restlessness (HP:0000711) | 1.76729753 |
| 141 | Intention tremor (HP:0002080) | 1.76153704 |
| 142 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.75965511 |
| 143 | Increased serum pyruvate (HP:0003542) | 1.74387730 |
| 144 | Rigidity (HP:0002063) | 1.73866709 |
| 145 | Exotropia (HP:0000577) | 1.73735353 |
| 146 | Medial flaring of the eyebrow (HP:0010747) | 1.73413720 |
| 147 | Cerebral edema (HP:0002181) | 1.73251743 |
| 148 | Hypothermia (HP:0002045) | 1.72873914 |
| 149 | Abnormality of glycolysis (HP:0004366) | 1.72371825 |
| 150 | Mutism (HP:0002300) | 1.72336333 |
| 151 | Dysmetric saccades (HP:0000641) | 1.71374435 |
| 152 | Syncope (HP:0001279) | 1.71362160 |
| 153 | Spastic gait (HP:0002064) | 1.70503067 |
| 154 | Pelvic girdle muscle weakness (HP:0003749) | 1.69986079 |
| 155 | Abnormality of the lower motor neuron (HP:0002366) | 1.69284021 |
| 156 | Cystic hygroma (HP:0000476) | 1.68188516 |
| 157 | Chronic diarrhea (HP:0002028) | 1.67302524 |
| 158 | Metaphyseal dysplasia (HP:0100255) | 1.66702390 |
| 159 | Shoulder girdle muscle weakness (HP:0003547) | 1.65790695 |
| 160 | Proximal amyotrophy (HP:0007126) | 1.65232892 |
| 161 | Renal cortical cysts (HP:0000803) | 1.64583570 |
| 162 | Neck muscle weakness (HP:0000467) | 1.63233499 |
| 163 | Menstrual irregularities (HP:0000858) | 1.62409717 |
| 164 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.60626721 |
| 165 | Atrioventricular block (HP:0001678) | 1.59394536 |
| 166 | Hyperkalemia (HP:0002153) | 1.58566260 |
| 167 | Heart block (HP:0012722) | 1.56952638 |
| 168 | Limb-girdle muscle weakness (HP:0003325) | 1.56128658 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 3.77498743 |
| 2 | MAP3K9 | 3.29980552 |
| 3 | EIF2AK3 | 3.26877002 |
| 4 | EPHA4 | 2.92438397 |
| 5 | MINK1 | 2.92167173 |
| 6 | NEK1 | 2.83198142 |
| 7 | MAP3K4 | 2.80298197 |
| 8 | MAP2K7 | 2.65621435 |
| 9 | CAMKK2 | 2.61017862 |
| 10 | NTRK1 | 2.54645573 |
| 11 | MAP2K4 | 2.34539873 |
| 12 | NEK9 | 2.26588382 |
| 13 | MAP3K12 | 2.26054308 |
| 14 | TRIM28 | 2.23841857 |
| 15 | RIPK4 | 2.06761535 |
| 16 | INSRR | 2.05857109 |
| 17 | MAP3K13 | 2.01048360 |
| 18 | ACVR1B | 1.93882582 |
| 19 | DAPK2 | 1.78740335 |
| 20 | MARK1 | 1.78085795 |
| 21 | KSR2 | 1.77452699 |
| 22 | WNK3 | 1.76291053 |
| 23 | LMTK2 | 1.75206074 |
| 24 | CASK | 1.74241855 |
| 25 | PIK3CG | 1.63731007 |
| 26 | CDK6 | 1.55903952 |
| 27 | CAMKK1 | 1.54374553 |
| 28 | STK38L | 1.51646874 |
| 29 | PLK2 | 1.51470366 |
| 30 | ARAF | 1.49284526 |
| 31 | SCYL2 | 1.48388878 |
| 32 | PHKG1 | 1.46457952 |
| 33 | PHKG2 | 1.46457952 |
| 34 | GRK5 | 1.45727605 |
| 35 | KSR1 | 1.44698230 |
| 36 | PDK4 | 1.44387662 |
| 37 | PDK3 | 1.44387662 |
| 38 | PAK6 | 1.42766029 |
| 39 | TTN | 1.42752531 |
| 40 | TNIK | 1.41295712 |
| 41 | PINK1 | 1.40887475 |
| 42 | STK24 | 1.33812599 |
| 43 | CDK5 | 1.28304385 |
| 44 | EPHA3 | 1.27806692 |
| 45 | CSNK1G3 | 1.23892607 |
| 46 | DAPK1 | 1.23058565 |
| 47 | CDK19 | 1.22136300 |
| 48 | PAK3 | 1.21361077 |
| 49 | MAP3K14 | 1.15752238 |
| 50 | CSNK1G1 | 1.13684536 |
| 51 | FRK | 1.13143234 |
| 52 | JAK1 | 1.12810571 |
| 53 | GRK7 | 1.11827838 |
| 54 | CSNK1A1L | 1.09832685 |
| 55 | MAP3K2 | 1.09413583 |
| 56 | CAMK2A | 1.06311238 |
| 57 | RPS6KB1 | 1.06300841 |
| 58 | FGFR3 | 1.04614098 |
| 59 | PRKCG | 1.04524031 |
| 60 | NTRK2 | 1.00873882 |
| 61 | FLT3 | 0.96489270 |
| 62 | MUSK | 0.94935541 |
| 63 | OXSR1 | 0.93475318 |
| 64 | MAP4K2 | 0.91572030 |
| 65 | SGK223 | 0.91332185 |
| 66 | SGK494 | 0.91332185 |
| 67 | RET | 0.90285589 |
| 68 | MET | 0.88481173 |
| 69 | MAPK13 | 0.88051188 |
| 70 | CSNK1G2 | 0.86433564 |
| 71 | OBSCN | 0.85908543 |
| 72 | CAMK2D | 0.84048484 |
| 73 | PTK2B | 0.83816477 |
| 74 | PRKD3 | 0.82723044 |
| 75 | SIK3 | 0.82330258 |
| 76 | MAPKAPK5 | 0.80851764 |
| 77 | PDK1 | 0.80756383 |
| 78 | PRKCE | 0.80437167 |
| 79 | TRPM7 | 0.80163421 |
| 80 | MAPK12 | 0.80016466 |
| 81 | CDK3 | 0.79866734 |
| 82 | BMPR1B | 0.79801911 |
| 83 | AKT3 | 0.78733746 |
| 84 | UHMK1 | 0.77057987 |
| 85 | WNK4 | 0.76291751 |
| 86 | LIMK1 | 0.76206012 |
| 87 | TIE1 | 0.75809739 |
| 88 | CLK1 | 0.75451212 |
| 89 | CAMK1 | 0.73148286 |
| 90 | FES | 0.72520524 |
| 91 | STK39 | 0.72316722 |
| 92 | STK3 | 0.72017779 |
| 93 | PNCK | 0.71441130 |
| 94 | CDK9 | 0.71011549 |
| 95 | LATS1 | 0.69450182 |
| 96 | BCKDK | 0.69035660 |
| 97 | PDPK1 | 0.67764413 |
| 98 | CDK14 | 0.67661167 |
| 99 | CAMK2B | 0.65759182 |
| 100 | PRKCH | 0.65265543 |
| 101 | NEK6 | 0.64125925 |
| 102 | EIF2AK1 | 0.63795627 |
| 103 | SGK2 | 0.63519695 |
| 104 | CCNB1 | 0.63087205 |
| 105 | SRPK1 | 0.62678124 |
| 106 | FER | 0.62203999 |
| 107 | MAPK11 | 0.61211161 |
| 108 | WNK1 | 0.60152185 |
| 109 | ERBB3 | 0.60041871 |
| 110 | MAP2K1 | 0.59658898 |
| 111 | STK38 | 0.58902271 |
| 112 | CAMK2G | 0.58863676 |
| 113 | SIK2 | 0.57133799 |
| 114 | BCR | 0.57027792 |
| 115 | LATS2 | 0.56889668 |
| 116 | BMPR2 | 0.56407210 |
| 117 | BRSK2 | 0.56264090 |
| 118 | PKN1 | 0.55237192 |
| 119 | STK11 | 0.54023860 |
| 120 | PRKAA1 | 0.52567603 |
| 121 | SGK1 | 0.52489164 |
| 122 | CAMK1G | 0.52337795 |
| 123 | ADRBK1 | 0.51398525 |
| 124 | HIPK2 | 0.51270913 |
| 125 | EIF2AK2 | 0.49645291 |
| 126 | BRSK1 | 0.49126869 |
| 127 | RAF1 | 0.48659783 |
| 128 | PDGFRA | 0.48653985 |
| 129 | MAP3K1 | 0.48300031 |
| 130 | MAP3K5 | 0.47993889 |
| 131 | PRKAA2 | 0.47084123 |
| 132 | CDK18 | 0.46345283 |
| 133 | PRKCQ | 0.46187122 |
| 134 | PRKCZ | 0.45838508 |
| 135 | DYRK1A | 0.45321604 |
| 136 | PRKACB | 0.45184638 |
| 137 | MELK | 0.44431297 |
| 138 | RPS6KA4 | 0.43380717 |
| 139 | MAP3K7 | 0.42697450 |
| 140 | PRKACA | 0.41821395 |
| 141 | CDK15 | 0.41352065 |
| 142 | JAK2 | 0.41025625 |
| 143 | NLK | 0.39757801 |
| 144 | AKT2 | 0.39339119 |
| 145 | SGK3 | 0.39303398 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Caffeine metabolism_Homo sapiens_hsa00232 | 3.11212775 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.61195017 |
| 3 | Nicotine addiction_Homo sapiens_hsa05033 | 2.56866843 |
| 4 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.36160313 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.15808841 |
| 6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.14395321 |
| 7 | Long-term potentiation_Homo sapiens_hsa04720 | 2.07651682 |
| 8 | Circadian entrainment_Homo sapiens_hsa04713 | 2.06843380 |
| 9 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.04109840 |
| 10 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.02118405 |
| 11 | Insulin secretion_Homo sapiens_hsa04911 | 1.99196181 |
| 12 | Olfactory transduction_Homo sapiens_hsa04740 | 1.98213441 |
| 13 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.96848959 |
| 14 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.86367783 |
| 15 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.85267063 |
| 16 | Morphine addiction_Homo sapiens_hsa05032 | 1.84671058 |
| 17 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.81626131 |
| 18 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.76944570 |
| 19 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.72785070 |
| 20 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.67161536 |
| 21 | Taste transduction_Homo sapiens_hsa04742 | 1.62704485 |
| 22 | Salivary secretion_Homo sapiens_hsa04970 | 1.58736916 |
| 23 | Renin secretion_Homo sapiens_hsa04924 | 1.55954117 |
| 24 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.44704557 |
| 25 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.42064577 |
| 26 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.39892031 |
| 27 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.39845167 |
| 28 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.35967091 |
| 29 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.35326177 |
| 30 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.35201647 |
| 31 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.33177368 |
| 32 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.32417904 |
| 33 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.27075591 |
| 34 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.26733401 |
| 35 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.25087211 |
| 36 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.22132141 |
| 37 | Cocaine addiction_Homo sapiens_hsa05030 | 1.20646164 |
| 38 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.20556006 |
| 39 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.18395688 |
| 40 | Long-term depression_Homo sapiens_hsa04730 | 1.18043819 |
| 41 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.17387273 |
| 42 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.16659156 |
| 43 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.14143141 |
| 44 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.13783489 |
| 45 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.12089293 |
| 46 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.11900154 |
| 47 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.10807403 |
| 48 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.10107864 |
| 49 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.07426946 |
| 50 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.06975933 |
| 51 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.06005337 |
| 52 | Alzheimers disease_Homo sapiens_hsa05010 | 1.05726560 |
| 53 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.05016653 |
| 54 | Parkinsons disease_Homo sapiens_hsa05012 | 1.04279031 |
| 55 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.99826722 |
| 56 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.99323131 |
| 57 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.98510101 |
| 58 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.98066702 |
| 59 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.93637433 |
| 60 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.93387422 |
| 61 | Peroxisome_Homo sapiens_hsa04146 | 0.93002931 |
| 62 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.92068652 |
| 63 | Bile secretion_Homo sapiens_hsa04976 | 0.91006341 |
| 64 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.89394826 |
| 65 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.88711684 |
| 66 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.86094978 |
| 67 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.84584510 |
| 68 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.84049163 |
| 69 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.83097576 |
| 70 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.82592803 |
| 71 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.81261179 |
| 72 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.79007774 |
| 73 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.78721678 |
| 74 | Gap junction_Homo sapiens_hsa04540 | 0.78375900 |
| 75 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.78176765 |
| 76 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.78158806 |
| 77 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.77419787 |
| 78 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.76239855 |
| 79 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.74685343 |
| 80 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.72981756 |
| 81 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.72555196 |
| 82 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.72317184 |
| 83 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.71276855 |
| 84 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.70423849 |
| 85 | Carbon metabolism_Homo sapiens_hsa01200 | 0.69740878 |
| 86 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.68708380 |
| 87 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.68121107 |
| 88 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.67293192 |
| 89 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.66337595 |
| 90 | Alcoholism_Homo sapiens_hsa05034 | 0.66086941 |
| 91 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.63022309 |
| 92 | Circadian rhythm_Homo sapiens_hsa04710 | 0.61458517 |
| 93 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.60389597 |
| 94 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.59052468 |
| 95 | Protein export_Homo sapiens_hsa03060 | 0.57918359 |
| 96 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.57732551 |
| 97 | Endometrial cancer_Homo sapiens_hsa05213 | 0.56371207 |
| 98 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.56180006 |
| 99 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.56159050 |
| 100 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.55931513 |
| 101 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.55773010 |
| 102 | Melanogenesis_Homo sapiens_hsa04916 | 0.55299543 |
| 103 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.55210840 |
| 104 | Glioma_Homo sapiens_hsa05214 | 0.54630445 |
| 105 | Focal adhesion_Homo sapiens_hsa04510 | 0.53247277 |
| 106 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.52464030 |
| 107 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.51880216 |
| 108 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.51392176 |
| 109 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.50764447 |
| 110 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.48833443 |
| 111 | Huntingtons disease_Homo sapiens_hsa05016 | 0.48565055 |
| 112 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.46926768 |
| 113 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.46874199 |
| 114 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.46669560 |
| 115 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.45085560 |
| 116 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.43493891 |
| 117 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.43422203 |
| 118 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.43167777 |
| 119 | Insulin resistance_Homo sapiens_hsa04931 | 0.43095670 |
| 120 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.42738336 |
| 121 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.41570090 |
| 122 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.40864686 |
| 123 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.37611466 |
| 124 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.36428544 |
| 125 | Prion diseases_Homo sapiens_hsa05020 | 0.36236262 |
| 126 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.36129312 |
| 127 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.35950908 |
| 128 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.35401045 |
| 129 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.34940018 |

